<SEC-DOCUMENT>0001558370-22-014511.txt : 20220921
<SEC-HEADER>0001558370-22-014511.hdr.sgml : 20220921
<ACCEPTANCE-DATETIME>20220921080013
ACCESSION NUMBER:		0001558370-22-014511
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20220921
DATE AS OF CHANGE:		20220921

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AYTU BIOPHARMA, INC
		CENTRAL INDEX KEY:			0001385818
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				470883144
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38247
		FILM NUMBER:		221255027

	BUSINESS ADDRESS:	
		STREET 1:		373 INVERNESS PARKWAY
		STREET 2:		SUITE 206
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112
		BUSINESS PHONE:		(720) 437-6580

	MAIL ADDRESS:	
		STREET 1:		373 INVERNESS PARKWAY
		STREET 2:		SUITE 206
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AYTU BIOSCIENCE, INC
		DATE OF NAME CHANGE:	20150609

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AYTU BIOSCIENCE, INC.
		DATE OF NAME CHANGE:	20150609

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Rosewind CORP
		DATE OF NAME CHANGE:	20070110
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>tmb-20220921xdefa14a.htm
<DESCRIPTION>DEFA14A
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 9/21/2022 10:53:05 AM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;text-align:center;border-bottom:1px solid #000000;border-top:3.0pt solid #000000;margin:0pt;"><font style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12.5pt;font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12.5pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Washington, DC 20549</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12.5pt;font-weight:bold;">SCHEDULE 14A</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(RULE 14a-101)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">INFORMATION REQUIRED IN PROXY STATEMENT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">SCHEDULE 14A INFORMATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Proxy Statement Pursuant to Section 14(A) of the</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Securities Exchange Act of 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;">Filed by the Registrant&#160;<font style="font-family:'Segoe UI Symbol';">&#9746;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;">Filed by a Party other than the Registrant <font style="font-family:'Segoe UI Symbol';">&#9744;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;">Check the appropriate box:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr><td style="vertical-align:top;width:4.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Segoe UI Symbol';">&#9744;</font></p></td><td style="vertical-align:top;width:95.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Preliminary Proxy Statement</p></td></tr><tr><td style="vertical-align:top;width:4.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:95.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:4.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Segoe UI Symbol';">&#9744;</font></p></td><td style="vertical-align:top;width:95.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</p></td></tr><tr><td style="vertical-align:top;width:4.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:95.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:4.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Segoe UI Symbol';">&#9744;</font></p></td><td style="vertical-align:top;width:95.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Definitive Proxy Statement</p></td></tr><tr><td style="vertical-align:top;width:4.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:95.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:4.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Segoe UI Symbol';">&#9746;</font></p></td><td style="vertical-align:top;width:95.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Definitive Additional Materials</p></td></tr><tr><td style="vertical-align:top;width:4.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:95.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:4.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Segoe UI Symbol';">&#9744;</font></p></td><td style="vertical-align:top;width:95.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Soliciting Material Pursuant to &#167; 240.14a-12</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;text-align:center;border-bottom:1px solid #000000;margin:0pt;"><b style="font-size:12.5pt;font-weight:bold;">Aytu BioPharma, Inc.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;">(Name of Registrant as Specified In Its Charter)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;text-align:center;border-bottom:1px solid #000000;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(Name of Person(s) Filing Proxy Statement if other Than the Registrant)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;">Payment of Filing Fee (Check the appropriate box):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr><td style="vertical-align:top;width:4.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Segoe UI Symbol';">&#9746;</font></p></td><td style="vertical-align:top;width:95.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">No fee required.</p></td></tr><tr><td style="vertical-align:top;width:4.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:95.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:4.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Segoe UI Symbol';">&#9744;</font></p></td><td style="vertical-align:top;width:95.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fee paid previously with preliminary materials.</p></td></tr><tr><td style="vertical-align:top;width:4.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:95.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:4.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Segoe UI Symbol';">&#9744;</font></p></td><td style="vertical-align:top;width:95.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;border-bottom:3.0pt solid #000000;border-top:1px solid #000000;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><font style="font-size:0pt;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:11pt;"><img src="tmb-20220921xdefa14a001.jpg" alt="Graphic" style="display:inline-block;height:99.85pt;left:0%;padding-bottom:0.65pt;position:relative;top:0pt;width:144.95pt;"></font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="color:#ff0000;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="color:#ff0000;font-size:11pt;font-weight:bold;">**** IMPORTANT REMINDER ****</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="color:#ff0000;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Dear Aytu BioPharma, Inc. Stockholder:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="font-size:11pt;">By now, you should have received your proxy material for the Aytu BioPharma, Inc. </font><font style="font-size:11pt;">Special Meeting</font><font style="font-size:11pt;"> which is scheduled to be held </font><font style="font-size:11pt;">on October 5, 2022</font><font style="font-size:11pt;">. &#160;</font><font style="font-size:11pt;">You are receiving this reminder letter because your votes were not yet processed at the time that this letter was mailed.&#160; If you have already voted, we would like to thank you for your vote.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="color:#ff0000;font-size:11pt;font-style:italic;font-weight:bold;">****PLEASE VOTE TODAY****</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="font-size:11pt;">Your Board recommends that you vote </font><b style="font-size:11pt;font-weight:bold;">FOR </b><font style="font-size:11pt;">proposals 1, and 2. Even if you plan on attending the meeting, we urge you to vote your shares now, so they can be tabulated prior to the meeting.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="font-size:11pt;">Your vote is extremely important. &#160;</font><b style="font-size:11pt;font-weight:bold;">PLEASE CAST YOUR VOTE TODAY.</b><font style="font-size:11pt;"> &#160;The fastest and easiest way to vote is by telephone or over the Internet. &#160;Instructions on how to vote your shares over the telephone or Internet are enclosed with this letter. &#160;Alternatively, you may sign and return the enclosed voting form in the envelope provided.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="font-size:11pt;">If you sign and return the enclosed voting form without indicating a different choice your shares will be voted as recommended by your Board of Directors.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="color:#ff0000;font-size:11pt;font-weight:bold;text-decoration-color:#ff0000;text-decoration-line:underline;text-decoration-style:solid;">WE URGE YOU TO EXERCISE YOUR RIGHT TO VOTE TODAY.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="font-size:11pt;font-style:italic;font-weight:bold;">If you have questions or need help voting your shares, please call our proxy solicitation firm, Morrow Sodali LLC at 1-800-607-0088.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="font-size:11pt;">Thank you for your investment in Aytu BioPharma, Inc. and for taking the time to vote your shares.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Sincerely,</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Joshua Disbrow</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Chairman and Chief Executive Officer</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tmb-20220921xdefa14a001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20220921xdefa14a001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #( 2(# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M44R1Q&"S$!0,DF@3T(KR\ALK:6>>18H8U+,['  KY7^+7Q-E\::JUM;.RZ9
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M\1Z1JEO?Z(49_ML39CPOWCGVKY-/_!)_X.%<>?K7_@3_ /6KWK0?A)HWP2^
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E%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
